553 related articles for article (PubMed ID: 19955429)
1. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.
Rimon G; Sidhu RS; Lauver DA; Lee JY; Sharma NP; Yuan C; Frieler RA; Trievel RC; Lucchesi BR; Smith WL
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):28-33. PubMed ID: 19955429
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cyclooxygenase-1 crystal structures: cross-talk between monomers comprising cyclooxygenase-1 homodimers.
Sidhu RS; Lee JY; Yuan C; Smith WL
Biochemistry; 2010 Aug; 49(33):7069-79. PubMed ID: 20669977
[TBL] [Abstract][Full Text] [Related]
3. A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin.
Ouellet M; Riendeau D; Percival MD
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14583-8. PubMed ID: 11717412
[TBL] [Abstract][Full Text] [Related]
4. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
[TBL] [Abstract][Full Text] [Related]
5. Whole-Body PET Imaging in Humans Shows That
Kim MJ; Anaya FJ; Manly LS; Lee JH; Hong J; Shrestha S; Telu S; Henry K; Santamaria JAM; Liow JS; Zanotti-Fregonara P; Shetty HU; Zoghbi SS; Pike VW; Innis RB
J Nucl Med; 2023 Jan; 64(1):159-164. PubMed ID: 35798558
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
Catella-Lawson F; Reilly MP; Kapoor SC; Cucchiara AJ; DeMarco S; Tournier B; Vyas SN; FitzGerald GA
N Engl J Med; 2001 Dec; 345(25):1809-17. PubMed ID: 11752357
[TBL] [Abstract][Full Text] [Related]
7. Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets.
Saxena A; Balaramnavar VM; Hohlfeld T; Saxena AK
Eur J Pharmacol; 2013 Dec; 721(1-3):215-24. PubMed ID: 24075938
[TBL] [Abstract][Full Text] [Related]
8. Current perspective on the cardiovascular effects of coxibs.
Konstam MA; Weir MR
Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory drugs in the 21st century.
Rainsford KD
Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib interferes to a limited extent with aspirin-mediated inhibition of platelets aggregation.
Ruzov M; Rimon G; Pikovsky O; Stepensky D
Br J Clin Pharmacol; 2016 Feb; 81(2):316-26. PubMed ID: 26456703
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis.
Bunimov N; Laneuville O
Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):268-77. PubMed ID: 19075637
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models.
Palomer A; Cabré F; Pascual J; Campos J; Trujillo MA; Entrena A; Gallo MA; García L; Mauleón D; Espinosa A
J Med Chem; 2002 Mar; 45(7):1402-11. PubMed ID: 11906281
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects.
Maenthaisong R; Tacconelli S; Sritara P; Del Boccio P; Di Francesco L; Sacchetta P; Archararit N; Aryurachai K; Patrignani P; Suthisisang C
Int J Immunopathol Pharmacol; 2013; 26(2):403-17. PubMed ID: 23755755
[TBL] [Abstract][Full Text] [Related]
14. Competition between low-dose aspirin and other NSAIDs for COX-1 binding and its clinical consequences for the drugs' antiplatelet effects.
Stepensky D; Rimon G
Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):41-52. PubMed ID: 25307725
[TBL] [Abstract][Full Text] [Related]
15. Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations.
Goltsov A; Maryashkin A; Swat M; Kosinsky Y; Humphery-Smith I; Demin O; Goryanin I; Lebedeva G
Eur J Pharm Sci; 2009 Jan; 36(1):122-36. PubMed ID: 19028575
[TBL] [Abstract][Full Text] [Related]
16. The structure of mammalian cyclooxygenases.
Garavito RM; Mulichak AM
Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
[TBL] [Abstract][Full Text] [Related]
17. Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats.
Akagi Y; Nio Y; Shimada S; Aoyama T
Biol Pharm Bull; 2011; 34(2):233-7. PubMed ID: 21415533
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
Hennan JK; Huang J; Barrett TD; Driscoll EM; Willens DE; Park AM; Crofford LJ; Lucchesi BR
Circulation; 2001 Aug; 104(7):820-5. PubMed ID: 11502709
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs.
Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
Biochemistry; 2018 Feb; 57(7):1236-1248. PubMed ID: 29345921
[TBL] [Abstract][Full Text] [Related]
20. Closing in on a stomach-sparing aspirin substitute.
Service RF
Science; 1996 Sep; 273(5282):1660. PubMed ID: 8830410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
